Xpo1 Transport Regulation
Xpo1 Transport Regulation - Related Videos
02:22
Regulated mRNA Transport
0 Views •
2020
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...
02:22
Regulated mRNA Transport
0 Views •
2023
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...
01:19
Membrane Asymmetry Regulating Transporters
0 Views •
2023
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry. Flippase Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
01:32
Transport and Acclimatization of Rodents for Research
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Transporting rodents for research requires procedures that minimize stress and maintain animal welfare during movement to minimize the influence on experimental outcomes. Transport cages should provide adequate ventilation,...
02:24
Regulation of Expression Occurs at Multiple Steps
0 Views •
2020
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence. Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
FAQs
Ran-GTP provides the nuclear-side condition that allows XPO1 to bind cargo carrying a nuclear export signal. After the complex reaches the cytoplasm, Ran-GTP hydrolysis promotes cargo release. This nucleotide-dependent cycle gives export directionality rather than allowing uncontrolled movement between compartments, linking the transport process to the spatial regulation of proteins and RNA molecules.
The pathway can alter whether regulatory proteins remain in the nucleus or become available in the cytoplasm. Because nuclear localization influences gene expression and cell-division control, changes in export can modify how these proteins function. In cancer cells, excessive or altered export may reduce the nuclear activity of growth-suppressive regulators and support continued proliferation or survival.
Nuclear export signals identify proteins and RNA molecules that XPO1 can transport. This recognition step determines which cellular regulators enter the export pathway, helping connect cargo identity with changes in intracellular location. In cancer research, the signal-dependent process is important because altered export of selected regulatory cargo can have different consequences from a general change in cellular transport.
Studying this pathway can clarify how cancer cells mislocalize tumor suppressors and other regulatory proteins. That information connects transport behavior with proliferation, cell division, and resistance to cell death. The resulting view is broader than gene expression alone: it shows how the location of regulatory molecules can contribute to malignant cell behavior and identify transport as a therapeutic opportunity.
Selective XPO1 inhibitors are designed to reduce the export activity that moves growth-suppressive cargo out of the nucleus. Their intended effect is greater nuclear retention, allowing those regulatory molecules to remain where they can influence growth control. This strategy provides a targeted therapeutic opportunity in cancer by addressing abnormal cargo localization rather than treating transport as an unrelated cellular process.
Cancer cells can exploit altered XPO1 activity to support proliferation and resist cell death, making the pathway relevant to treatment design. Research on its transport cycle has guided development of selective XPO1 inhibitors that aim to counter this exploitation. The therapeutic rationale is to restore nuclear retention of growth-suppressive cargo and potentially reestablish regulatory control in cancer cells.